Monthly Archives: September 2023
HAMILTON, ON, Sept. 27, 2023 /PRNewswire/ — Premier Clinical Trial Network (PCTN), a leading clinical research and site management organization, is thrilled to announce the addition of distinguished researcher Dr. Eva Lonn to its team of principal investigators. Continue Reading Doctor Eva Lonn Headshot Dr. Lonn is joining PCTN seeking new opportunities to conduct groundbreaking […]
Sep
By Ailbhe Macmahon For Mailonline Published: 08:27 EDT, 27 September 2023 | Updated: 08:43 EDT, 27 September 2023 Advertisement
Sep
The overwhelming feeling is one of carefully controlled chaos. They throw their curveballs with glee, such as Welcome To The Next Level Above Human – a techno-rock sugar rush of a track that would make Electric Callboy seem tame – and almost crunkcore interlude Burn Again, which falls just about on the right side of […]
Sep
From NIH Research Matters In Parkinson’s disease, neurons that normally produce a compound called dopamine start to die in the part of the brain that controls movement. This eventually leads to symptoms such as shaking, stiffness, and difficulty with balance and coordination. Some drugs used to treat the condition boost dopamine levels. These can relieve […]
Sep
Media Advisory Wednesday, September 27, 2023 NIH-funded study identifies managing maternal stress as a possible way to lessen impacts of prenatal infection on infant socioemotional and cognitive development. What For mothers who experience high stress during their pregnancy, prenatal COVID-19 infection may be associated with an increased risk for impaired attention and delayed socioemotional and […]
Sep
Wed, 27 Sep 2023 18:50:16 GMT (1695840616655) 91ea59363219d9928211d09a831b6bae9e73e7a4 18d9567f5260393589c62b27e2a97cc4992e683e News Weather Features Traffic Game Center Watch Now 86 Thu 94 Fri 92 by News 3 Staff Wed, September 27th 2023, 6:37 PM UTC Courtesy: Vegas Golden Knights Loading …
Sep
Pune: Mylab Discovery Solutions announced a ground-breaking advancement in new-born screening (NBS) with the introduction of its patent-pending Point-of-Care Device named MyNeoShield for New-born Screening on Wednesday. Newborn screening (NBS) is a critical public health program involving the testing of newborn infants for specific genetic, metabolic, and congenital disorders shortly after birth. Left undiagnosed and […]